Viewing Study NCT06305702


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-01-17 @ 10:15 AM
Study NCT ID: NCT06305702
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2024-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer
Sponsor: Liaoning Cancer Hospital & Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Metastatic Breast Cancer View
Keywords: